Breaking: Only 48 Hours Left to Vote in the Shocking 2026 Leadership Election – Who Will Transform SITC?

The Society for Immunotherapy of Cancer (SITC) has officially opened its election process for key leadership positions within the organization. The election, which is open to all active members, will determine the next Vice President, Secretary/Treasurer, and three At-Large Directors. Voting will conclude on Friday, May 15, at 11:59 p.m. EDT.

In a noteworthy push for representation, Kristen Hege, a member of the Board of Directors at KSQ Therapeutics, Inc., took to LinkedIn to encourage participation in the election. She highlighted her candidacy for Vice President and the candidacy of her colleague Oli Finn for the Board of Directors. Both are founding co-organizers of the SITC Women in Immunotherapy Network.

Hege's post emphasizes a strong commitment to the SITC community, stating, “Such wonderful colleagues and SITC devotees. We would appreciate your vote.” The involvement of women leaders in this election is particularly significant, as it reflects ongoing efforts to enhance diversity and representation in the field of immunotherapy, an area of growing importance in cancer treatment.

The SITC, established to promote research and education in cancer immunotherapy, plays a vital role in the advancement of this transformative medical field. Immunotherapy has revolutionized cancer treatment, providing new avenues for patients who previously had limited options. As the election unfolds, the outcomes will not only shape the leadership of SITC but also influence the future direction of cancer immunotherapy research and advocacy.

As members cast their votes, the significance of engaging in professional associations like SITC cannot be overstated. Such organizations foster collaboration, knowledge sharing, and innovation, all critical to the ongoing battle against cancer. The participation in these elections is a call to action for those within the immunotherapy community to take an active role in shaping its future.

With the election date approaching, the urgency for SITC members to make their voices heard grows. It remains to be seen how the results will reflect the community's priorities and aspirations for advancing cancer treatments through immunotherapy.